Lipid Modification Database
Tag Content
LipidDB ID
LipidDB-9606-01073
Entry Name
UniProt Accession
Theoretical PI
8.55
Molecular Weight
60877.86
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
Scavenger receptor class B member 1
Protein Synonyms/Alias
SRB1; CD36 and LIMPII analogous 1; CLA-1; CD36 antigen-like 1; Collagen type I receptor, thrombospondin receptor-like 1; SR-BI; CD36;
Gene Name
SCARB1
Gene Synonyms/Alias
CD36L1; CLA1;
Created Date
10-OCT-2003
 Lipid Modification Sites 
 Position   Sequence Form   Peptide   References   Modification Type 
3
Canonical
*****MGCSAKARWA
[1]
S-Palmitoylation
462
Canonical
LLLVPVICQIRSQVG
[1]
S-Palmitoylation
Organism
Homo sapiens (Human)
NCBI Taxa ID
9606
Reference
[1] Predicted from GPS-Lipid
Functional Description
Receptor for different ligands such as phospholipids, cholesterol ester, lipoproteins, phosphatidylserine and apoptotic cells. Probable receptor for HDL, located in particular region of the plasma membrane, called caveolae. Facilitates the flux of free and esterified cholesterol between the cell surface and extracellular donors and acceptors, such as HDL and to a lesser extent, apoB-containing lipoproteins and modified lipoproteins. Probably involved in the phagocytosis of apoptotic cells, via its phosphatidylserine binding activity. Receptor for hepatitis C virus glycoprotein E2. Binding between SCARB1 and E2 was found to be independent of the genotype of the viral isolate. Plays an important role in the uptake of HDL cholesteryl ester (By similarity).
Sequence Annotation
Topological domain: 1 11 Cytoplasmic.
Transmembrane: 12 32 Helical.
Topological domain: 33 443 Extracellular.
Transmembrane: 444 464 Helical.
Topological domain: 465 552 Cytoplasmic.
Protein Length
552 AA.
Protein Sequence
(Canonical)
MGCSAKARWA AGALGVAGLL CAVLGAVMIV MVPSLIKQQV LKNVRIDPSS LSFNMWKEIP  60
IPFYLSVYFF DVMNPSEILK GEKPQVRERG PYVYREFRHK SNITFNNNDT VSFLEYRTFQ  120
FQPSKSHGSE SDYIVMPNIL VLGAAVMMEN KPMTLKLIMT LAFTTLGERA FMNRTVGEIM  180
WGYKDPLVNL INKYFPGMFP FKDKFGLFAE LNNSDSGLFT VFTGVQNISR IHLVDKWNGL  240
SKVDFWHSDQ CNMINGTSGQ MWPPFMTPES SLEFYSPEAC RSMKLMYKES GVFEGIPTYR  300
FVAPKTLFAN GSIYPPNEGF CPCLESGIQN VSTCRFSAPL FLSHPHFLNA DPVLAEAVTG  360
LHPNQEAHSL FLDIHPVTGI PMNCSVKLQL SLYMKSVAGI GQTGKIEPVV LPLLWFAESG  420
AMEGETLHTF YTQLVLMPKV MHYAQYVLLA LGCVLLLVPV ICQIRSQVGA GQRAARADSH  480
SLACWGKGAS DRTLWPTAAW SPPPAAVLRL CRSGSGHCWG LRSTLASFAC RVATTLPVLE  540
GLGPSLGGGT GS                                                      552
FASTA
(Canonical)
>LipidDB-9606-01073|Q8WTV0
MGCSAKARWAAGALGVAGLLCAVLGAVMIVMVPSLIKQQVLKNVRIDPSSLSFNMWKEIP
IPFYLSVYFFDVMNPSEILKGEKPQVRERGPYVYREFRHKSNITFNNNDTVSFLEYRTFQ
FQPSKSHGSESDYIVMPNILVLGAAVMMENKPMTLKLIMTLAFTTLGERAFMNRTVGEIM
WGYKDPLVNLINKYFPGMFPFKDKFGLFAELNNSDSGLFTVFTGVQNISRIHLVDKWNGL
SKVDFWHSDQCNMINGTSGQMWPPFMTPESSLEFYSPEACRSMKLMYKESGVFEGIPTYR
FVAPKTLFANGSIYPPNEGFCPCLESGIQNVSTCRFSAPLFLSHPHFLNADPVLAEAVTG
LHPNQEAHSLFLDIHPVTGIPMNCSVKLQLSLYMKSVAGIGQTGKIEPVVLPLLWFAESG
AMEGETLHTFYTQLVLMPKVMHYAQYVLLALGCVLLLVPVICQIRSQVGAGQRAARADSH
SLACWGKGASDRTLWPTAAWSPPPAAVLRLCRSGSGHCWGLRSTLASFACRVATTLPVLE
GLGPSLGGGTGS
Gene Ontology
GO:0005901; C:caveola; TAS:BHF-UCL
GO:0009986; C:cell surface; IEA:Ensembl
GO:0030666; C:endocytic vesicle membrane; TAS:Reactome
GO:0070062; C:extracellular vesicular exosome; IDA:UniProt
GO:0005887; C:integral component of plasma membrane; IEA:Ensembl
GO:0005765; C:lysosomal membrane; IDA:UniProtKB
GO:0031528; C:microvillus membrane; IEA:Ensembl
GO:0005886; C:plasma membrane; IDA:BHF-UCL
GO:0005545; F:1-phosphatidylinositol binding; TAS:BHF-UCL
GO:0034186; F:apolipoprotein A-I binding; IPI:BHF-UCL
GO:0034185; F:apolipoprotein binding; IPI:BHF-UCL
GO:0008035; F:high-density lipoprotein particle binding; IEA:Ensembl
GO:0070506; F:high-density lipoprotein particle receptor activity; IDA:BHF-UCL
GO:0001530; F:lipopolysaccharide binding; IDA:BHF-UCL
GO:0001875; F:lipopolysaccharide receptor activity; IDA:BHF-UCL
GO:0030169; F:low-density lipoprotein particle binding; IDA:BHF-UCL
GO:0001786; F:phosphatidylserine binding; ISS:BHF-UCL
GO:0005215; F:transporter activity; TAS:ProtInc
GO:0044406; P:adhesion of symbiont to host; IMP:BHF-UCL
GO:0006702; P:androgen biosynthetic process; IEA:Ensembl
GO:0043534; P:blood vessel endothelial cell migration; IEA:Ensembl
GO:0007155; P:cell adhesion; IEA:InterPro
GO:0006707; P:cholesterol catabolic process; IEA:Ensembl
GO:0033344; P:cholesterol efflux; ISS:BHF-UCL
GO:0042632; P:cholesterol homeostasis; ISS:BHF-UCL
GO:0070508; P:cholesterol import; ISS:BHF-UCL
GO:0032497; P:detection of lipopolysaccharide; IDA:BHF-UCL
GO:0001935; P:endothelial cell proliferation; IEA:Ensembl
GO:0034384; P:high-density lipoprotein particle clearance; IDA:BHF-UCL
GO:0034375; P:high-density lipoprotein particle remodeling; ISS:BHF-UCL
GO:0015920; P:lipopolysaccharide transport; IDA:BHF-UCL
GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IDA:GOC
GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
GO:0034383; P:low-density lipoprotein particle clearance; ISS:BHF-UCL
GO:0015914; P:phospholipid transport; ISS:BHF-UCL
GO:0010886; P:positive regulation of cholesterol storage; IDA:BHF-UCL
GO:0010595; P:positive regulation of endothelial cell migration; TAS:BHF-UCL
GO:0051000; P:positive regulation of nitric-oxide synthase activity; IDA:BHF-UCL
GO:0010867; P:positive regulation of triglyceride biosynthetic process; ISS:BHF-UCL
GO:0006898; P:receptor-mediated endocytosis; IDA:GOC
GO:0043654; P:recognition of apoptotic cell; IDA:BHF-UCL
GO:0050764; P:regulation of phagocytosis; IC:BHF-UCL
GO:0010899; P:regulation of phosphatidylcholine catabolic process; ISS:BHF-UCL
GO:0043691; P:reverse cholesterol transport; IEP:BHF-UCL
GO:0044281; P:small molecule metabolic process; TAS:Reactome
GO:0070328; P:triglyceride homeostasis; ISS:BHF-UCL
GO:0016032; P:viral process; IEA:UniProtKB-KW
GO:0042060; P:wound healing; TAS:BHF-UCL
Interpro
InterPro; IPR002159; CD36
InterPro; IPR005428; CD36_antigen
Pfam
Pfam; PF01130; CD36;
SMART
PROSITE
PRINTS
PRINTS; PR01610; CD36ANTIGEN;
PRINTS; PR01609; CD36FAMILY;